Actigraphic monitoring (actigraphy) of circadian locomotor activity in schizophrenic patients with acute neuroleptic-induced akathisia

Author： Poyurovsky M.   Nave R.   Epstein R.   Tzischinsky O.   Schneidman M.   Barnes T.R.E.   Weizman A.   Lavie P.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.10, Iss.3, 2000-05, pp. : 171-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A beta-adrenoceptor antagonist, carteolol, in the treatment of neuroleptic-induced akathisia

By Aoba A.   Murasaki M.   Kamijima K.   Yagi G.   Komemushi S.   Miura S.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 391-391

Elsevier

Access to resources Recommend Favorite

Risk factors for the development of neuroleptic induced akathisia

By Miller C.H.   Hummer M.   Oberbauer H.   Kurzthaler I.   DeCol C.   Fleischhacker W.W.  

European Neuropsychopharmacology, Vol. 7, Iss. 1, 1997-02 ,pp. : 51-55

Elsevier

Access to resources Recommend Favorite

Serum iron levels in schizophrenic patients with or without akathisia

By Kuloglu M.   Atmaca M.   Ustundag B.   Canatan H.   Gecici O.   Tezcan E.  

European Neuropsychopharmacology, Vol. 13, Iss. 2, 2003-03 ,pp. : 67-71

Elsevier

Access to resources Recommend Favorite

The effect of vitamin E addition to acute neuroleptic treatment on the emergence of extrapyramidal side effects in schizophrenic patients: An open label study

By Dorfman-Etrog P.   Hermesh H.   Prilipko L.   Weizman A.   Munitz H.  

European Neuropsychopharmacology, Vol. 9, Iss. 6, 1999-12 ,pp. : 475-477

Elsevier

Access to resources Recommend Favorite

Ritanserin in neuroleptic induced akathisia: a double blind comparison with placebo

By De Col C.   Miller C.H.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 349-349

Elsevier

Access to resources Recommend Favorite